Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from HIMS

Hims & Hers Stock Jumps On Long-Awaited Foray Into Testosterone

Hims stock popped Wednesday after the telemedicine giant announced its long-awaited foray into offering testosterone replacement therapy.

Investors Business Daily

Hims & Hers Bets On Hormonal Health To Revive Investor Confidence

Hims & Hers Bets On Hormonal Health To Revive Investor Confidence

Hims Hers Health Inc. (NYSE:HIMS) launched a new category in men’s health on Wednesday, offering access to affordable and personalized treatment plans for low testosterone.

Discounted Ozempic Could Deflate ETF Optimism Around Hims & Hers

Discounted Ozempic Could Deflate ETF Optimism Around Hims & Hers

Hims Hers Health Inc (NYSE:HIMS) investors can’t catch a break. Less than two months since Novo Nordisk AS (NYSE:NVO) terminated its Wegovy partnership with the telehealth company abruptly, the pharma giant is again in the news, this time partnering with GoodRx Holdings Inc (NASDAQ:GDRX) to provide discounted access to Ozempic…

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Ozempic Boom: Hims & Eli Lilly Lead Healthcare Bets

The race inside the weight loss industry is ramping up, leaving investors with three names to choose from in how they want to play this theme.

Insiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift4

A chip stock that recently partnered with NVIDIA. Now, a key company insider is buying over $160 million in shares, a bullish signal to investors.

5 Ways ‘Hims’ Searches Are Shaping Men’s Health Conversations

In recent years, men’s health has shifted from being a quiet, private matter to an open conversation fueled by technology and data. One of the biggest players in that transformation is Hims, the telehealth platform known for discreetly delivering prescription and wellness products straight to consumers. Search data from Hims…

Hims & Hers Stock Slips As FTC Probe Into Subscription Practices Resurfaces

Hims Hers Health Inc. (NYSE:HIMS) stock is trading lower following a media report revealing that the Federal Trade Commission (FTC) has been investigating the company’s business practices for over a year.

inkl

Read news from The Economist, FT, and more,
with one subscription

Hims & Hers Remains Outside Novo Nordisk's Growing Legal Storm For Now

Hims & Hers Remains Outside Novo Nordisk's Growing Legal Storm For Now

Hims Hers Health Inc. (NYSE:HIMS) has been one of 2025’s hottest telehealth stocks, nearly doubling in value year to date, but a deepening clash with Novo Nordisk A/S (NYSE:NVO) over compounded weight-loss drugs, and shifting FDA rules, has turned momentum into headwinds, sending shares sliding 10% in the past three…

MarketBeat Week in Review – 08/04 - 08/08

Stocks were higher for the week as investors overlooked tariff uncertainty, but the bulls may get tested by next week's data on inflation and retail sales

Diagnosis: Hims & Hers' August Price Dip Is an Opportunity to Buy

Diagnosis: Hims & Hers' August Price Dip Is an Opportunity to Buy

Hims & Hers falls into a buying opportunity followng the Q2 release and guidance update but investors shouldn't rush to get in, wait for this market to bottom.

Hims & Hers Health Stock Plunges Over 13% In Tuesday Pre-Market: What's Going On?

Hims & Hers Health Stock Plunges Over 13% In Tuesday Pre-Market: What's Going On?

Hims Hers Health Inc. (NYSE:HIMS) plunged 13.1% in Tuesday pre-market after the digital health company reported second-quarter revenue on Monday that missed Wall Street expectations.

Why Hims Stock Plunged — And Why It Could Still Remain A 'Market Darling'

Hims stock tumbled Tuesday after the obesity kingpin lagged second-quarter sales forecasts, though profit beat estimates.

Investors Business Daily

Will Hims & Hers Fall Along With Novo Nordisk?

Will Hims & Hers Fall Along With Novo Nordisk?

Novo Nordisk shares are trading as low as 35% of their 52-week highs, making Hims & Hers investors nervous whether a selloff is coming.

Hims & Hers Stock Up, Nearing All-Time High As Weight-Loss Giants Stumble

Hims & Hers Stock Up, Nearing All-Time High As Weight-Loss Giants Stumble

Shares of telehealth company Hims Hers Health Inc (NYSE:HIMS) are up Thursday afternoon, and at one point, approached a new all-time high. The rally comes amid significant headwinds for major pharmaceutical companies in the lucrative weight-loss drug market.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Hims & Hers Health Closes In On Buy Point As Earnings Loom

Hims stock is climbing back from a steep drop within a base. Shares have climbed nearly 29% during the month and outperformed 98% of stocks.

Novo Nordisk Charts Signal Weakness Amid Wegovy Warning, Expert Says 'Could've Played Out VERY Differently If They Had Embraced $HIMS'

Weight-loss drugmaker Novo Nordisk A/S (NYSE:NVO)’s technical chart is displaying a largely bearish trend amid a profit warning issued by the company tied to its blockbuster obesity drug Wegovy. However, this expert believes that the Danish pharmaceutical giant could have avoided some trouble if it hadn’t ended its partnership with…

Hims & Hers Stock Could Rocket To Meme Stock Fame — If Short Sellers Feel The Squeeze

Hims Hers Health, Inc. (NYSE:HIMS) has seen a surge in retail investor interest, which positions it as one of the most high-profile candidates for the next “meme stock” rally.

The Independent UK

‘Drunk’ United Airlines pilot was forced into rehab for alcoholism. He actually had a concussion, lawsuit claims

Exclusive: Capt. Mike Tallon was sent for inpatient treatment, attended AA meetings, and blew into a breathalyzer twice daily, when he says he should have been treated for head trauma

Get all your
news in one place.

100’s of premium titles.
One news app.

What's Going On With Hims & Hers Health Stock Today?

Hims Hers Health Inc (NYSE:HIMS) shares surged in early trading Wednesday before pulling back. The stock was still up marginally at last check after the company announced a planned Canadian expansion.

The Independent UK

Obesity drug prices are dropping, but getting a steady supply remains a challenge

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging

Why Hims & Hers Is a Buy Below $35 After Its 16% Pullback

Hims & Hers stock dipped after Novo Nordisk pulled back its partnership for a weight loss drug distribution, though that may not mean much.

Benzinga Bulls And Bears: Nvidia, Micron, HIMS — And Markets Soar On Mideast And Tariff Relief

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

What's Going On With Hims & Hers Health Stock Today?

Hims Hers Health Inc. (NYSE:HIMS) shares are trading higher Thursday. The stock appears to be bouncing back a bit after selling off to start the week. Here’s a look at what you need to know.

HIMS Crashes On Novo GLP-1 Fallout: Buy The Dip Or Bail?

Telehealth darling Hims Hers Health Inc (NYSE:HIMS) got slapped with a 34% stock crash on Monday. Novo Nordisk A/S (NYSE:NVO) ended their relationship – and it wasn't amicable.

Why Hims & Hers Stock Could Be a Multi-Bagger in the Making

Hims & Hers stock keeps giving investors more reasons to buy, and has all the right factors to turn it into a potential multi-bagger investment.

People

Gabriel OsorioMazilli

Jeffrey Neal Johnson

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

The Independent

the Federal Reserve

United Airlines

The Federal Trade Commission

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

302,394 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play